MEDNAX, Inc. (MD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

MEDNAX, Inc. (MD) is up 10.0% since the beginning of the year. At $24 per share, MD is trading 5.9% below its 52-week high of $25. Investors who bought $1,000 worth of MD shares 5 years ago would now be looking at an investment worth $745.

MEDNAX, Inc. (MD) has returned 9.96% so far this year and 77.91% over the past 12 months. Over the last ten years, MD has returned -10.33% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Sep 20, 1995, MD's average daily return is +0.07%, while the average monthly return is +1.24%. At this rate, an investment would double in approximately 4.7 years.

Historically, 54% of months were positive and 46% were negative. The best month was Jun 2000 with a return of +69.3%, while the worst month was Feb 1999 at -52.2%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 7 months.

On a daily basis, MD closed higher 51% of trading days. The best single day was Mar 25, 1999 with a return of +70.5%, while the worst single day was Feb 12, 1999 at -47.8%.

MEDNAX, Inc. has an annualized alpha of 10.30%, beta of 0.76, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since September 20, 1995.

• This stock participated in 106.09% of S&P 500 Index downside but only 89.75% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

MD ranks 85 for risk / return — in the top 85% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the MEDNAX, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the MEDNAX, Inc. was 92.08%, occurring on Jun 11, 2024. The portfolio has not yet recovered.

The current MEDNAX, Inc. drawdown is 72.48%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of MEDNAX, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how MEDNAX, Inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.